問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Search Result

Search Result

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

Study Statistics

5200Cases

20022027

Total

5200

  • I

    559

  • I/II

    241

  • II

    1202

  • II/III

    132

  • III

    2548

  • IV

    102

  • Others

    355

Principal Investigator

2747Doctors

Co-Principal Investigator

8707Doctors

Hospital

123Sites

List

5200Cases

2021-02-01 - 2026-12-31

Phase III

Active
A phase III, randomized, assessor-blinded, two-stage, two-way crossover, active-and-placebo controlled trial was conducted to evaluate the efficacy and safety of using chlorhexidine gluconate (Aqua)-containing antibacterial wipes as a topical disinfectant in healthy volunteers.

  • Condition/Disease

    Hand disinfection before surgery, hand disinfection in the ward, and skin disinfection for patients before surgery.

  • Test Drug

    liniment

Participate Sites
4Sites

Recruiting4Sites

2022-04-13 - 2023-12-20

Phase III

-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
2Sites

Not yet recruiting2Sites

2022-05-01 - 2025-05-09

Phase III

Completed
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
5Sites

Terminated5Sites

2022-05-10 - 2026-06-30

Phase III

Active
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Not yet recruiting1Sites

Recruiting5Sites

2022-06-01 - 2032-12-31

Phase III

Active
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
5Sites

Recruiting5Sites

聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB